ACW pivotal Alzheimers trial database lock - results mid-Nov
Filed with ASX ·
6ix is reading this filing.
Actinogen Medical Limited on 6ix
Story so far
Earlier from Actinogen Medical
- ACW September 2026 quarterly activity report & Appendix 4C
- Actinogen XanaMIA pivotal Alzheimer’s disease trial completes final patient visit, with topline results on track for November
- Underwriting of unlisted options completed
- ACW Alzheimers pivotal trial completes last patient visit
- ACW unlisted options fully underwritten
Follow Actinogen Medical into a list and get an email when it puts out news.
Follow Actinogen Medical